Mazumder Razib, Abdullah Ahmed, Ahmed Dilruba, Hussain Arif
Laboratory Sciences and Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka-1212, Bangladesh.
Antibiotics (Basel). 2020 Nov 11;9(11):796. doi: 10.3390/antibiotics9110796.
The emergence of multidrug-resistant (MDR) () clonal lineages with high virulence potential is alarming. Lack of sufficient data on molecular epidemiology of such pathogens from countries with high infection burden, such as Bangladesh, hinders management and infection control measures. In this study, we assessed the population structure, virulence potential and antimicrobial susceptibility of clinical isolates from Dhaka, Bangladesh. A high prevalence of MDR (69%) and extended-spectrum β-lactamase production (ESBL) (51%) was found. Most isolates were susceptible to amikacin (95%), meropenem (94%) and nitrofurantoin (89%) antibiotics. A high prevalence of ST131 (22%) and ST95 (9%) followed by ST69 (4%) and ST73 (3%) was observed. Phylogroups B2 (46%), B1 (16%), D (10%) and F (9%) were prominent. (52%) and (5%) were the most prevalent ESBL and carbapenem resistance genes, respectively. Moreover, the predominant pathotype identified was extraintestinal pathogenic (ExPEC) (41%) followed by enteric pathogens (11%). In conclusion, our results suggest the transmission of clonal groups amidst diverse population that are associated with high virulence potential and MDR phenotype. This is of high concern and mandates more efforts towards molecular surveillance of antimicrobial resistance (AMR) in clinically significant pathogens.
具有高毒力潜力的多重耐药(MDR)克隆谱系的出现令人担忧。来自感染负担较高的国家(如孟加拉国)的此类病原体分子流行病学数据不足,阻碍了管理和感染控制措施。在本研究中,我们评估了来自孟加拉国达卡的临床分离株的种群结构、毒力潜力和抗菌药物敏感性。发现MDR(69%)和产超广谱β-内酰胺酶(ESBL)(51%)的患病率很高。大多数分离株对阿米卡星(95%)、美罗培南(94%)和呋喃妥因(89%)抗生素敏感。观察到ST131(22%)和ST95(9%)的高患病率,其次是ST69(4%)和ST73(3%)。B2(46%)、B1(16%)、D(10%)和F(9%)菌系较为突出。blaCTX-M(52%)和blaKPC(5%)分别是最常见的ESBL和碳青霉烯耐药基因。此外,鉴定出的主要致病型是肠外致病性大肠杆菌(ExPEC)(41%),其次是肠道病原体(11%)。总之,我们的结果表明,在具有高毒力潜力和MDR表型的不同大肠杆菌种群中,克隆菌群在传播。这令人高度关注,需要加大对临床重要病原体抗菌药物耐药性(AMR)分子监测的力度。